SER Serina Therapeutics
- 4.830
- -0.170-3.40%
Serina Therapeutics News
Serina Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Broadwood Partners, L.P.(2.1%),Broadwood Capital, Inc.(2.1%), etc.
Serina Therapeutics | 8-K: Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Serina Therapeutics | 10-Q: Quarterly report
Serina Therapeutics | ARS: Annual Report to Security Holders
Serina Therapeutics | DEFA14A: Others
Serina Therapeutics | DEF 14A: Definitive information statements
Serina Therapeutics | DEFC14A: Others
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MINTZ STEVEN
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEDGER STEVEN A
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CURHAN GREGORY S
Serina Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer CURHAN GREGORY S
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MINTZ STEVEN
Analysis
Price Target
No Data
No Data